Company intelligence / Profile preview

BioWorld Today

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

BioWorld is a premier news and intelligence provider for the global biopharmaceutical and medical technology industries. It delivers daily reporting and in-depth analysis on drug development, clinical trials, regulatory milestones, and corporate finance. The publication suite includes BioWorld Today, BioWorld MedTech, and BioWorld Asia, serving a global audience of biotech executives, investors, and researchers. As part of Clarivate, BioWorld integrates its editorial expertise with comprehensive data sets to provide actionable insights for the life sciences sector. The service is widely recognized for its real-time coverage of the most critical developments in the biotech and med-tech markets.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on BioWorld Today.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioWorld Today.

Explore the full profile